High-dose intravenous gammaglobulin for myasthenia gravis. 1984

P Gajdos, and H Outin, and D Elkharrat, and D Brunel, and P de Rohan-Chabot, and J C Raphael, and M Goulon, and C Goulon-Goeau, and E Morel

UI MeSH Term Description Entries
D007116 Immunization, Passive Transfer of immunity from immunized to non-immune host by administration of serum antibodies, or transplantation of lymphocytes (ADOPTIVE TRANSFER). Convalescent Plasma Therapy,Immunoglobulin Therapy,Immunotherapy, Passive,Normal Serum Globulin Therapy,Passive Antibody Transfer,Passive Transfer of Immunity,Serotherapy,Passive Immunotherapy,Therapy, Immunoglobulin,Antibody Transfer, Passive,Passive Immunization,Therapy, Convalescent Plasma,Transfer, Passive Antibody
D007263 Infusions, Parenteral The administration of liquid medication, nutrient, or other fluid through some other route than the alimentary canal, usually over minutes or hours, either by gravity flow or often by infusion pumping. Intra-Abdominal Infusions,Intraperitoneal Infusions,Parenteral Infusions,Peritoneal Infusions,Infusion, Intra-Abdominal,Infusion, Intraperitoneal,Infusion, Parenteral,Infusion, Peritoneal,Infusions, Intra-Abdominal,Infusions, Intraperitoneal,Infusions, Peritoneal,Intra Abdominal Infusions,Intra-Abdominal Infusion,Intraperitoneal Infusion,Parenteral Infusion,Peritoneal Infusion
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009157 Myasthenia Gravis A disorder of neuromuscular transmission characterized by fatigable weakness of cranial and skeletal muscles with elevated titers of ACETYLCHOLINE RECEPTORS or muscle-specific receptor tyrosine kinase (MuSK) autoantibodies. Clinical manifestations may include ocular muscle weakness (fluctuating, asymmetric, external ophthalmoplegia; diplopia; ptosis; and weakness of eye closure) and extraocular fatigable weakness of facial, bulbar, respiratory, and proximal limb muscles. The disease may remain limited to the ocular muscles (ocular myasthenia). THYMOMA is commonly associated with this condition. Anti-MuSK Myasthenia Gravis,MuSK MG,MuSK Myasthenia Gravis,Muscle-Specific Receptor Tyrosine Kinase Myasthenia Gravis,Muscle-Specific Tyrosine Kinase Antibody Positive Myasthenia Gravis,Myasthenia Gravis, Generalized,Myasthenia Gravis, Ocular,Anti MuSK Myasthenia Gravis,Generalized Myasthenia Gravis,Muscle Specific Receptor Tyrosine Kinase Myasthenia Gravis,Muscle Specific Tyrosine Kinase Antibody Positive Myasthenia Gravis,Myasthenia Gravis, Anti-MuSK,Myasthenia Gravis, MuSK,Ocular Myasthenia Gravis
D005260 Female Females
D005719 gamma-Globulins Serum globulins that migrate to the gamma region (most positively charged) upon ELECTROPHORESIS. At one time, gamma-globulins came to be used as a synonym for immunoglobulins since most immunoglobulins are gamma globulins and conversely most gamma globulins are immunoglobulins. But since some immunoglobulins exhibit an alpha or beta electrophoretic mobility, that usage is in decline. gamma-Globulin,gamma Globulin,gamma Globulins
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

P Gajdos, and H Outin, and D Elkharrat, and D Brunel, and P de Rohan-Chabot, and J C Raphael, and M Goulon, and C Goulon-Goeau, and E Morel
April 1984, Lancet (London, England),
P Gajdos, and H Outin, and D Elkharrat, and D Brunel, and P de Rohan-Chabot, and J C Raphael, and M Goulon, and C Goulon-Goeau, and E Morel
October 1984, Lancet (London, England),
P Gajdos, and H Outin, and D Elkharrat, and D Brunel, and P de Rohan-Chabot, and J C Raphael, and M Goulon, and C Goulon-Goeau, and E Morel
March 1988, Hiroshima journal of medical sciences,
P Gajdos, and H Outin, and D Elkharrat, and D Brunel, and P de Rohan-Chabot, and J C Raphael, and M Goulon, and C Goulon-Goeau, and E Morel
January 1998, Journal of neurology,
P Gajdos, and H Outin, and D Elkharrat, and D Brunel, and P de Rohan-Chabot, and J C Raphael, and M Goulon, and C Goulon-Goeau, and E Morel
April 1993, Italian journal of neurological sciences,
P Gajdos, and H Outin, and D Elkharrat, and D Brunel, and P de Rohan-Chabot, and J C Raphael, and M Goulon, and C Goulon-Goeau, and E Morel
December 1985, Archives of neurology,
P Gajdos, and H Outin, and D Elkharrat, and D Brunel, and P de Rohan-Chabot, and J C Raphael, and M Goulon, and C Goulon-Goeau, and E Morel
June 1987, Journal of neurology,
P Gajdos, and H Outin, and D Elkharrat, and D Brunel, and P de Rohan-Chabot, and J C Raphael, and M Goulon, and C Goulon-Goeau, and E Morel
April 1985, Lancet (London, England),
P Gajdos, and H Outin, and D Elkharrat, and D Brunel, and P de Rohan-Chabot, and J C Raphael, and M Goulon, and C Goulon-Goeau, and E Morel
April 2002, Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology,
P Gajdos, and H Outin, and D Elkharrat, and D Brunel, and P de Rohan-Chabot, and J C Raphael, and M Goulon, and C Goulon-Goeau, and E Morel
January 2000, Pediatric neurology,
Copied contents to your clipboard!